# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Idiopathic juxtafoveal retinal telangiectasia

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-9 of 9 results.
Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)
Status: Completed
Last Changed: Sep 22, 2009
First Received: Jul 20, 2007
Disease(s): Type 2 Idiopathic Macular Telangiectasia
Intervention(s): Intravitreal injection ranibizumab
Locations: Department of Ophthalmology, University of Bonn, Bonn, Germany
A Study to Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1)
Status: Completed
Last Changed: Sep 02, 2020
First Received: Sep 13, 2018
Disease(s): Retinal Telangiectasis, Idiopathic Juxtafoveal Retinal Telangiectasia
Intervention(s): THR-317 8mg
Locations: Hôpital Lariboisière, Paris, France
Hôpital Cochin, Paris, France
Hôpital Ophtalmique Jules-Gonin, Lausanne, Switzerland
The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel)
Status: Completed
Last Changed: Jun 23, 2017
First Received: May 16, 2011
Disease(s): Idiopathic Juxtafoveal Telangiectasia
Intervention(s): zeaxanthin, zeaxanthin
Locations: Moran Eye Center, University of Utah, Salt Lake City, Utah, United States
Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel)
Status: Completed
Last Changed: Nov 22, 2016
First Received: Apr 04, 2011
Disease(s): Idiopathic Juxtafoveal Telangiectasia
Intervention(s): NT-501 implant
Locations: Jules Stein Eye Institute, Los Angeles, California, United States
Retina Associates of Cleveland, Cleveland, Ohio, United States
Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia
Status: Completed
Last Changed: Jul 23, 2008
First Received: Mar 23, 2007
Disease(s): Retina, Telangiectasis
Intervention(s): Intravitreal Injection of Bevacizumab (1.25 mg/0.05ml)
Locations: From the Retina and Vitreous Service, Department of Ophthalmology. Sao Rafael Hospital, Monte Tabor Foudation, Salvador, Bahia, Brazil
Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial
Status: Completed
Last Changed: Nov 14, 2012
First Received: Sep 19, 2006
Disease(s): Telangiectasia
Intervention(s): Ranibizumab, Ranibizumab
Locations: The Wilmer Eye Institute at Johns Hopkins, Baltimore, Maryland, United States
Effect of Avastin in Juxtafoveal Telangiectasias
Status: Unknown status
Last Changed: Dec 04, 2006
First Received: Dec 04, 2006
Disease(s): Telangiectasis
Intervention(s): Bevacizumab, Intravitreal injection of Bevacizumab
Locations: Asociacion para Evitar la Ceguera en Mexico, Mexico, DF, Mexico
Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation
Status: Completed
Last Changed: Jul 02, 2017
First Received: Apr 05, 2007
Disease(s): Telangiectasia
Intervention(s): Ranibizumab
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation
Status: Completed
Last Changed: Jul 02, 2017
First Received: Apr 05, 2007
Disease(s): Telangiectasia
Intervention(s): Ranibizumab
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States